林艺 has an unusually complete background spanning research, consulting, entrepreneurship, and investing—from a biology PhD at Columbia and MBA at University of Chicago to roles at McKinsey, co-founding a biotech company, and becoming managing partner at BioVenture. He describes specialized funds like BioVenture as "hematopoietic stem cells" for biotech startups, emphasizing that professional funds should provide ongoing support in management, resources, and follow-on funding rather than just capital.